Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:dextroamphetamine
|
| gptkbp:approvalYear |
2013
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
N06BA02
|
| gptkbp:countryOfOperation |
gptkb:United_States
|
| gptkbp:form |
gptkb:tablet
|
| gptkbp:genericAvailable |
yes
|
| https://www.w3.org/2000/01/rdf-schema#label |
Zenzedi
|
| gptkbp:legalStatus |
prescription only
Schedule II controlled substance (US) |
| gptkbp:manufacturer |
gptkb:Arbor_Pharmaceuticals
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
anxiety
loss of appetite increased heart rate insomnia dry mouth |
| gptkbp:usedFor |
gptkb:attention_deficit_hyperactivity_disorder
narcolepsy |
| gptkbp:bfsParent |
gptkb:dextroamphetamine
|
| gptkbp:bfsLayer |
7
|